BRD9 and acute myeloid leukemia: To determine BRD9-dependent functions in AML cells, we inhibited acetyl-lysine sensing by the BRD9 bromodomain through the competitive inhibitor I-BRD9 (74), followed by growth assays and genomic assays for BAF complex binding, nascent transcription, and chromatin accessibility.